 | • レポートコード：MRC2Q12-18971 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、78ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ダブラフェニブのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ダブラフェニブのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ダブラフェニブの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ダブラフェニブのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのダブラフェニブの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のダブラフェニブの売上および2028年までの予測に焦点を当てています。 ダブラフェニブのグローバル主要企業には、Novartis、Biosynth、VladaChem、Ambeedなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ダブラフェニブ市場は、タイプとアプリケーションによって区分されます。世界のダブラフェニブ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 非小細胞肺癌、甲状腺癌、その他 【アプリケーション別セグメント】 臨床、研究機関 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ダブラフェニブ製品概要 - タイプ別市場（非小細胞肺癌、甲状腺癌、その他） - アプリケーション別市場（臨床、研究機関） - 調査の目的 ・エグゼクティブサマリー - 世界のダブラフェニブ販売量予測2017-2028 - 世界のダブラフェニブ売上予測2017-2028 - ダブラフェニブの地域別販売量 - ダブラフェニブの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ダブラフェニブ販売量 - 主要メーカー別ダブラフェニブ売上 - 主要メーカー別ダブラフェニブ価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（非小細胞肺癌、甲状腺癌、その他） - ダブラフェニブのタイプ別販売量 - ダブラフェニブのタイプ別売上 - ダブラフェニブのタイプ別価格 ・アプリケーション別市場規模（臨床、研究機関） - ダブラフェニブのアプリケーション別販売量 - ダブラフェニブのアプリケーション別売上 - ダブラフェニブのアプリケーション別価格 ・北米市場 - 北米のダブラフェニブ市場規模（タイプ別、アプリケーション別） - 主要国別のダブラフェニブ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのダブラフェニブ市場規模（タイプ別、アプリケーション別） - 主要国別のダブラフェニブ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のダブラフェニブ市場規模（タイプ別、アプリケーション別） - 主要国別のダブラフェニブ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のダブラフェニブ市場規模（タイプ別、アプリケーション別） - 主要国別のダブラフェニブ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのダブラフェニブ市場規模（タイプ別、アプリケーション別） - 主要国別のダブラフェニブ市場規模（トルコ、サウジアラビア） ・企業情報 Novartis、Biosynth、VladaChem、Ambeed ・産業チェーン及び販売チャネル分析 - ダブラフェニブの産業チェーン分析 - ダブラフェニブの原材料 - ダブラフェニブの生産プロセス - ダブラフェニブの販売及びマーケティング - ダブラフェニブの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ダブラフェニブの産業動向 - ダブラフェニブのマーケットドライバー - ダブラフェニブの課題 - ダブラフェニブの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Dabrafenib is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Dabrafenib is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Dabrafenib is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Dabrafenib include Novartis, Biosynth, VladaChem and Ambeed, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Dabrafenib manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Dabrafenib market. Further, it explains the major drivers and regional dynamics of the global Dabrafenib market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Novartis
Biosynth
VladaChem
Ambeed
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Dabrafenib Segment by Type
Non-small Cell Lung Cancer
Thyroid Cancer
Other
Dabrafenib Segment by Application
Clinical
Research Institute
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Dabrafenib market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Dabrafenib, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Dabrafenib, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dabrafenib, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dabrafenib sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Dabrafenib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Dabrafenib sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis, Biosynth, VladaChem and Ambeed, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Dabrafenib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Dabrafenib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dabrafenib sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Dabrafenib Product Introduction
1.2 Market by Type
1.2.1 Global Dabrafenib Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Non-small Cell Lung Cancer
1.2.3 Thyroid Cancer
1.2.4 Other
1.3 Market by Application
1.3.1 Global Dabrafenib Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinical
1.3.3 Research Institute
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dabrafenib Sales Estimates and Forecasts 2017-2028
2.2 Global Dabrafenib Revenue Estimates and Forecasts 2017-2028
2.3 Global Dabrafenib Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dabrafenib Sales by Region
2.4.1 Global Dabrafenib Sales by Region (2017-2022)
2.4.2 Global Sales Dabrafenib by Region (2023-2028)
2.5 Global Dabrafenib Revenue by Region
2.5.1 Global Dabrafenib Revenue by Region (2017-2022)
2.5.2 Global Dabrafenib Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dabrafenib Sales by Manufacturers
3.1.1 Global Top Dabrafenib Manufacturers by Sales (2017-2022)
3.1.2 Global Dabrafenib Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dabrafenib in 2021
3.2 Global Dabrafenib Revenue by Manufacturers
3.2.1 Global Dabrafenib Revenue by Manufacturers (2017-2022)
3.2.2 Global Dabrafenib Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dabrafenib Revenue in 2021
3.3 Global Dabrafenib Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dabrafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dabrafenib Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dabrafenib Sales by Type
4.1.1 Global Dabrafenib Historical Sales by Type (2017-2022)
4.1.2 Global Dabrafenib Forecasted Sales by Type (2023-2028)
4.1.3 Global Dabrafenib Sales Market Share by Type (2017-2028)
4.2 Global Dabrafenib Revenue by Type
4.2.1 Global Dabrafenib Historical Revenue by Type (2017-2022)
4.2.2 Global Dabrafenib Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dabrafenib Revenue Market Share by Type (2017-2028)
4.3 Global Dabrafenib Price by Type
4.3.1 Global Dabrafenib Price by Type (2017-2022)
4.3.2 Global Dabrafenib Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dabrafenib Sales by Application
5.1.1 Global Dabrafenib Historical Sales by Application (2017-2022)
5.1.2 Global Dabrafenib Forecasted Sales by Application (2023-2028)
5.1.3 Global Dabrafenib Sales Market Share by Application (2017-2028)
5.2 Global Dabrafenib Revenue by Application
5.2.1 Global Dabrafenib Historical Revenue by Application (2017-2022)
5.2.2 Global Dabrafenib Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dabrafenib Revenue Market Share by Application (2017-2028)
5.3 Global Dabrafenib Price by Application
5.3.1 Global Dabrafenib Price by Application (2017-2022)
5.3.2 Global Dabrafenib Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dabrafenib Market Size by Type
6.1.1 North America Dabrafenib Sales by Type (2017-2028)
6.1.2 North America Dabrafenib Revenue by Type (2017-2028)
6.2 North America Dabrafenib Market Size by Application
6.2.1 North America Dabrafenib Sales by Application (2017-2028)
6.2.2 North America Dabrafenib Revenue by Application (2017-2028)
6.3 North America Dabrafenib Market Size by Country
6.3.1 North America Dabrafenib Sales by Country (2017-2028)
6.3.2 North America Dabrafenib Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Dabrafenib Market Size by Type
7.1.1 Europe Dabrafenib Sales by Type (2017-2028)
7.1.2 Europe Dabrafenib Revenue by Type (2017-2028)
7.2 Europe Dabrafenib Market Size by Application
7.2.1 Europe Dabrafenib Sales by Application (2017-2028)
7.2.2 Europe Dabrafenib Revenue by Application (2017-2028)
7.3 Europe Dabrafenib Market Size by Country
7.3.1 Europe Dabrafenib Sales by Country (2017-2028)
7.3.2 Europe Dabrafenib Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dabrafenib Market Size by Type
8.1.1 Asia Pacific Dabrafenib Sales by Type (2017-2028)
8.1.2 Asia Pacific Dabrafenib Revenue by Type (2017-2028)
8.2 Asia Pacific Dabrafenib Market Size by Application
8.2.1 Asia Pacific Dabrafenib Sales by Application (2017-2028)
8.2.2 Asia Pacific Dabrafenib Revenue by Application (2017-2028)
8.3 Asia Pacific Dabrafenib Market Size by Region
8.3.1 Asia Pacific Dabrafenib Sales by Region (2017-2028)
8.3.2 Asia Pacific Dabrafenib Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Dabrafenib Market Size by Type
9.1.1 Latin America Dabrafenib Sales by Type (2017-2028)
9.1.2 Latin America Dabrafenib Revenue by Type (2017-2028)
9.2 Latin America Dabrafenib Market Size by Application
9.2.1 Latin America Dabrafenib Sales by Application (2017-2028)
9.2.2 Latin America Dabrafenib Revenue by Application (2017-2028)
9.3 Latin America Dabrafenib Market Size by Country
9.3.1 Latin America Dabrafenib Sales by Country (2017-2028)
9.3.2 Latin America Dabrafenib Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dabrafenib Market Size by Type
10.1.1 Middle East and Africa Dabrafenib Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dabrafenib Revenue by Type (2017-2028)
10.2 Middle East and Africa Dabrafenib Market Size by Application
10.2.1 Middle East and Africa Dabrafenib Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dabrafenib Revenue by Application (2017-2028)
10.3 Middle East and Africa Dabrafenib Market Size by Country
10.3.1 Middle East and Africa Dabrafenib Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dabrafenib Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Dabrafenib Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Dabrafenib Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Biosynth
11.2.1 Biosynth Corporation Information
11.2.2 Biosynth Overview
11.2.3 Biosynth Dabrafenib Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biosynth Dabrafenib Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biosynth Recent Developments
11.3 VladaChem
11.3.1 VladaChem Corporation Information
11.3.2 VladaChem Overview
11.3.3 VladaChem Dabrafenib Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 VladaChem Dabrafenib Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 VladaChem Recent Developments
11.4 Ambeed
11.4.1 Ambeed Corporation Information
11.4.2 Ambeed Overview
11.4.3 Ambeed Dabrafenib Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ambeed Dabrafenib Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ambeed Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dabrafenib Industry Chain Analysis
12.2 Dabrafenib Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dabrafenib Production Mode & Process
12.4 Dabrafenib Sales and Marketing
12.4.1 Dabrafenib Sales Channels
12.4.2 Dabrafenib Distributors
12.5 Dabrafenib Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dabrafenib Industry Trends
13.2 Dabrafenib Market Drivers
13.3 Dabrafenib Market Challenges
13.4 Dabrafenib Market Restraints
14 Key Findings in The Global Dabrafenib Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer